Advertisement

Archives of Toxicology

, Volume 93, Issue 7, pp 1993–2006 | Cite as

Proteomic analysis of hippocampal proteins in acrylamide-exposed Wistar rats

  • Daichi Nagashima
  • Lingyi Zhang
  • Yuki Kitamura
  • Sahoko Ichihara
  • Eri Watanabe
  • Cai Zong
  • Yuko Yamano
  • Toshihiro Sakurai
  • Shinji Oikawa
  • Gaku IchiharaEmail author
Organ Toxicity and Mechnisms
  • 233 Downloads

Abstract

Acrylamide has been used industrially and also found in certain foods cooked at high temperatures. Previous reports described acrylamide-related human intoxication who presented with ataxia, memory impairment, and/or illusion. The aim of this study was to characterize the molecular mechanisms of neurotoxicity of acrylamide by analyzing the expression levels of various proteins in the hippocampus of rats exposed to acrylamide. Male Wistar rats were administered acrylamide by gavage at 0, 2, and 20 mg/kg for 1 week or 0, 0.2, 2, and 20 mg/kg for 5 weeks. At the end of the experiment, the hippocampus was dissected out and proteins were extracted for two-dimensional difference gel electrophoresis combined with matrix-assisted laser-desorption ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF/TOF/MS). MALDI-TOF/TOF/MS identified significant changes in two proteins in the 1-week and 22 proteins in the 5-week exposure groups. These changes were up-regulation in 9 and down-regulation in 13 proteins in the hippocampus of rats exposed to acrylamide at 20 mg/kg for 5 weeks. PANTHER overrepresentation test based on the GO of biological process showed significant overrepresentation in proteins annotated to nicotinamide nucleotide metabolic process, coenzyme biosynthetic process, pyruvate metabolic process, and carbohydrate metabolic process. The test also showed significant overrepresentation in proteins annotated to creatinine kinase activity for the GO of molecular function as well as myelin sheath, cytoplasmic part, and cell body for the GO of cellular component. Comparison with a previous proteomic study on hippocampal proteins in rats exposed to 1-bromopropane identified triosephosphate isomerase, mitochondrial creatine kinase U-type, creatine kinase β-type and proteasome subunit α type-1 as proteins affected by exposure to acrylamide and 1-bromopropane, suggesting a common mechanism of neurotoxicity for soft electrophiles.

Keywords

Acrylamide Proteomic analysis Neurotoxicology Triosephosphate isomerase Soft electrophiles 

Notes

Acknowledgements

This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 26293148, 16H02965, 17H06396, and 17H07105. The authors thank Ms. Yoshiko Murakata for the generous help in proteomic analysis, Dr. Xiao Zhang for help in molecular analysis, and Ms. Yurina Wakayama, Mr. Kyo Morita, Ms. Hana Katano, and Ms. Mami Sakai for their generous help in the experiment. We thank Ms. Satoko Arai for the excellent secretarial support. We also acknowledge the help and support of Dr. Toshio Nakadate throughout the study.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

Supplementary material

204_2019_2484_MOESM1_ESM.pptx (92 kb)
Supplementary Fig. 1 Changes in body weight of rats exposed by gavage to acrylamide at 0, 2, 20 mg/kg bw for 1 week or 0, 0.2, 2, 20 mg/kg bw for 5 weeks. Daily exposure to acrylamide at 20mg/kg bw was associated with a significant body weight loss from Day 30. The value is the mean ± SD (n=5 rats in each group), *p < 0.05, compared with the control by one-way ANOVA followed by Dunnett’s test. Supplementary Fig. 2 a, b, c, d) Changes in weight of different body organs during the 1-week study period. Numbers on the abscissa represent the dose of acrylamide (0 mg/kg, control group; 2 mg/kg group; 20 mg/kg group. n=6 in each group). e, f, g, h, I, j) Changes in weight of different body organs during the 5-week study period. Numbers on the abscissa represent the dose of acrylamide (0 mg/kg, control group, n =5; 0.2 mg/kg group, n=3; 2 mg/kg group, n=5; 20 mg/kg group, n=5). The weight of the brain, adrenal gland, liver, kidney and spleen at day 35 was significantly lower in the 20 mg/kg acrylamide group compared with the control. Data are mean ± SD, *p<0.05, compared with the control, by one-way ANOVA followed by Dunnett’s test (PPTX 91 kb)

References

  1. Bae SY, Sheverdin V, Maeng J, Lyoo IK, Han PL, Lee K (2017) Immunohistochemical localization of translationally controlled tumor protein in axon terminals of mouse hippocampal neurons. Exp Neurobiol 26:82–89CrossRefGoogle Scholar
  2. Bingol B, Schuman EM (2006) Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 441:1144–1148CrossRefGoogle Scholar
  3. Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer’s disease: current status and prospects for the future. J Intern Med 284:643–663CrossRefGoogle Scholar
  4. Burek JD, Albee RR, Beyer JE, Bell TJ, Carreon RM, Morden DC et al (1980) Subchronic toxicity of acrylamide administered to rats in the drinking water followed by up to 144 days of recovery. J Environ Pathol Toxicol 4:157–182Google Scholar
  5. Burklen TS, Schlattner U, Homayouni R, Gough K, Rak M, Szeghalmi A et al (2006) The creatine kinase/creatine connection to alzheimer’s disease: Ck-inactivation, app-ck complexes and focal creatine deposits. J Biomed Biotechnol 2006:35936CrossRefGoogle Scholar
  6. Cai F, Frey JU, Sanna PP, Behnisch T (2010) Protein degradation by the proteasome is required for synaptic tagging and the heterosynaptic stabilization of hippocampal late-phase long-term potentiation. Neuroscience 169:1520–1526CrossRefGoogle Scholar
  7. Calleman CJ, Wu Y, He F, Tian G, Bergmark E, Zhang S et al (1994) Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol Appl Pharmacol 126:361–371CrossRefGoogle Scholar
  8. Casaletto KB, Elahi FM, Bettcher BM, Neuhaus J, Bendlin BB, Asthana S et al (2017) Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers. Neurology 89:1782–1788CrossRefGoogle Scholar
  9. Chang J, Oikawa S, Iwahashi H, Kitagawa E, Takeuchi I, Yuda M et al (2014) Expression of proteins associated with adipocyte lipolysis was significantly changed in the adipose tissues of the obese spontaneously hypertensive/ndmcr-cp rat. Diabetol Metab Syndr 6:8CrossRefGoogle Scholar
  10. Djakovic SN, Schwarz LA, Barylko B, DeMartino GN, Patrick GN (2009) Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase ii. J Biol Chem 284:26655–26665CrossRefGoogle Scholar
  11. Dong C, Upadhya SC, Ding L, Smith TK, Hegde AN (2008) Proteasome inhibition enhances the induction and impairs the maintenance of late-phase long-term potentiation. Learn Mem 15:335–347CrossRefGoogle Scholar
  12. Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SP, Muller DJ et al (2005) Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 43:365–410CrossRefGoogle Scholar
  13. Ehlers MD (2003) Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 6:231–242CrossRefGoogle Scholar
  14. Fennell TR, Friedman MA (2005) Comparison of acrylamide metabolism in humans and rodents. Adv Exp Med Biol 561:109–116CrossRefGoogle Scholar
  15. Fennell TR, Sumner SC, Snyder RW, Burgess J, Spicer R, Bridson WE et al (2005) Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 85:447–459CrossRefGoogle Scholar
  16. Fennell TR, Sumner SC, Snyder RW, Burgess J, Friedman MA (2006) Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol Sci 93:256–267CrossRefGoogle Scholar
  17. Ghanayem BI, McDaniel LP, Churchwell MI, Twaddle NC, Snyder R, Fennell TR et al (2005) Role of cyp2e1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol Sci 88:311–318CrossRefGoogle Scholar
  18. Hopkins A (1970) The effect of acrylamide on the peripheral nervous system of the baboon. J Neurol Neurosurg Psychiatry 33:805–816CrossRefGoogle Scholar
  19. Huang Z, Ichihara S, Oikawa S, Chang J, Zhang L, Takahashi M et al (2011) Proteomic analysis of hippocampal proteins of f344 rats exposed to 1-bromopropane. Toxicol Appl Pharmacol 257:93–101CrossRefGoogle Scholar
  20. Huang Z, Ichihara S, Oikawa S, Chang J, Zhang L, Subramanian K et al (2012) Proteomic identification of carbonylated proteins in f344 rat hippocampus after 1-bromopropane exposure. Toxicol Appl Pharmacol 263:44–52CrossRefGoogle Scholar
  21. Ichihara G, Kitoh J, Yu X, Asaeda N, Iwai H, Kumazawa T et al (2000) 1-bromopropane, an alternative to ozone layer depleting solvents, is dose-dependently neurotoxic to rats in long-term inhalation exposure. Toxicol Sci 55:116–123CrossRefGoogle Scholar
  22. Ichihara G, Miller J, Ziolkowska A, Itohara S, Takeuchi Y (2002) Neurological disorders in three workers exposed to 1-bromopropane. J Occup Health 44:1–7CrossRefGoogle Scholar
  23. Igisu H, Goto I, Kawamura Y, Kato M, Izumi K (1975) Acrylamide encephaloneuropathy due to well water pollution. J Neurol Neurosurg Psychiatry 38:581–584CrossRefGoogle Scholar
  24. Karpova A, Mikhaylova M, Thomas U, Knopfel T, Behnisch T (2006) Involvement of protein synthesis and degradation in long-term potentiation of schaffer collateral ca1 synapses. J Neurosci 26:4949–4955CrossRefGoogle Scholar
  25. Kesson CM, Baird AW, Lawson DH (1977) Acrylamide poisoning. Postgrad Med J 53:16–17CrossRefGoogle Scholar
  26. Kim Y, Cha SJ, Choi HJ, Kim K (2017) Omega class glutathione s-transferase: antioxidant enzyme in pathogenesis of neurodegenerative diseases. Oxid Med Cell Longev 2017:5049532Google Scholar
  27. Kohriyama K, Matsuoka M, Igisu H (1994) Effects of acrylamide and acrylic acid on creatine kinase activity in the rat brain. Arch Toxicol 68:67–70CrossRefGoogle Scholar
  28. Lin D, Saleh S, Liebler DC (2008) Reversibility of covalent electrophile-protein adducts and chemical toxicity. Chem Res Toxicol 21:2361–2369CrossRefGoogle Scholar
  29. Liu Z, Song G, Zou C, Liu G, Wu W, Yuan T et al (2015) Acrylamide induces mitochondrial dysfunction and apoptosis in bv-2 microglial cells. Free Radic Biol Med 84:42–53CrossRefGoogle Scholar
  30. LoPachin RM, Gavin T (2012) Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry. Environ Health Perspect 120:1650–1657CrossRefGoogle Scholar
  31. Lu ZR, Zou HC, Park SJ, Park D, Shi L, Oh SH et al (2009) The effects of acrylamide on brain creatine kinase: inhibition kinetics and computational docking simulation. Int J Biol Macromol 44:128–132CrossRefGoogle Scholar
  32. Majersik JJ, Caravati EM, Steffens JD (2007) Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin Toxicol (Phila) 45:270–276CrossRefGoogle Scholar
  33. Martinez de Arrieta C, Morte B, Coloma A, Bernal J (1999) The human rc3 gene homolog, nrgn contains a thyroid hormone-responsive element located in the first intron. Endocrinology 140:335–343CrossRefGoogle Scholar
  34. Matsuoka M, Igisu H, Lin J, Inoue N (1990) Effects of acrylamide and n,n’-methylene-bis-acrylamide on creatine kinase activity. Brain Res 507:351–353CrossRefGoogle Scholar
  35. Matsuoka M, Matsumura H, Igisu H (1996) Creatine kinase activities in brain and blood: possible neurotoxic indicator of acrylamide intoxication. Occup Environ Med 53:468–471CrossRefGoogle Scholar
  36. Meyer LE, Machado LB, Santiago AP, da-Silva WS, De Felice FG, Holub O et al (2006) Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent adp re-cycling activity. J Biol Chem 281:37361–37371CrossRefGoogle Scholar
  37. Mi H, Muruganujan A, Casagrande JT, Thomas PD (2013) Large-scale gene function analysis with the panther classification system. Nat Protoc 8:1551–1566CrossRefGoogle Scholar
  38. Mohideen SS, Ichihara S, Banu S, Liu F, Kitoh J, Ichihara G (2009) Changes in neurotransmitter receptor expression levels in rat brain after 4-week exposure to 1-bromopropane. Neurotoxicology 30:1078–1083CrossRefGoogle Scholar
  39. Mohideen SS, Ichihara S, Subramanian K, Huang Z, Naito H, Kitoh J et al (2013) Effects of exposure to 1-bromopropane on astrocytes and oligodendrocytes in rat brain. J Occup Health 55:29–38CrossRefGoogle Scholar
  40. Morimoto M (1975) Occurence of human cases intoxicated with well water contaminated with acrylamide in fukuoka prefecture. Water Waste 17:51–62Google Scholar
  41. Morita K, Zhang L, Hara S, Ichinose H, Sakai M, Wakayama Y, et al (2017) Exposure to acrylamide reduces noradernaline level, noradrenergic axons, and adult neurogenesis in brain of rats similarly to exposure to 1-bromopropane. Toxicologist Suppl Toxicol Sci 178Google Scholar
  42. Oikawa S, Yamada T, Minohata T, Kobayashi H, Furukawa A, Tada-Oikawa S et al (2009) Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic Biol Med 46:1472–1477CrossRefGoogle Scholar
  43. Pennisi M, Malaguarnera G, Puglisi V, Vinciguerra L, Vacante M, Malaguarnera M (2013) Neurotoxicity of acrylamide in exposed workers. Int J Environ Res Public Health 10:3843–3854CrossRefGoogle Scholar
  44. Portelius E, Olsson B, Hoglund K, Cullen NC, Kvartsberg H, Andreasson U et al (2018) Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathol 136:363–376CrossRefGoogle Scholar
  45. Prineas J (1969) The pathogenesis of dying-back polyneuropathies. Ii. An ultrastructural study of experimental acrylamide intoxication in the cat. J Neuropathol Exp Neurol 28:598–621CrossRefGoogle Scholar
  46. Rinetti GV, Schweizer FE (2010) Ubiquitination acutely regulates presynaptic neurotransmitter release in mammalian neurons. J Neurosci 30:3157–3166CrossRefGoogle Scholar
  47. Samukawa M, Ichihara G, Oka N, Kusunoki S (2012) A case of severe neurotoxicity associated with exposure to 1-bromopropane, an alternative to ozone-depleting or global-warming solvents. Arch Intern Med 172:1257–1260CrossRefGoogle Scholar
  48. Schlattner U, Tokarska-Schlattner M, Wallimann T (2006) Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 1762:164–180CrossRefGoogle Scholar
  49. Sumner SC, MacNeela JP, Fennell TR (1992) Characterization and quantitation of urinary metabolites of [1,2,3-13c]acrylamide in rats and mice using 13c nuclear magnetic resonance spectroscopy. Chem Res Toxicol 5:81–89CrossRefGoogle Scholar
  50. Sumner SC, Fennell TR, Moore TA, Chanas B, Gonzalez F, Ghanayem BI (1999) Role of cytochrome p450 2e1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 12:1110–1116CrossRefGoogle Scholar
  51. Sumner SC, Williams CC, Snyder RW, Krol WL, Asgharian B, Fennell TR (2003) Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. Toxicol Sci 75:260–270CrossRefGoogle Scholar
  52. Tajes M, Eraso-Pichot A, Rubio-Moscardo F, Guivernau B, Ramos-Fernandez E, Bosch-Morato M et al (2014) Methylglyoxal produced by amyloid-beta peptide-induced nitrotyrosination of triosephosphate isomerase triggers neuronal death in Alzheimer’s disease. J Alzheimers Dis 41:273–288CrossRefGoogle Scholar
  53. Takeuchi Y, Ono Y, Hisanaga N, Kitoh J, Sugiura Y (1980) A comparative study on the neurotoxicity of n-pentane, n-hexane, and n-heptane in the rat. Br J Ind Med 37:241–247Google Scholar
  54. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) (2011) Safety evaluation of certain contaminants in food. in WHO FOOD ADDITIVES SERIES: 63 FAO JECFA MONOGRAPHS 8, World Health Organization, Geneva, Food and Agriculture Organization of the United Nations, Rome, p 791Google Scholar
  55. Tyl RW, Marr MC, Myers CB, Ross WP, Friedman MA (2000) Relationship between acrylamide reproductive and neurotoxicity in male rats. Reprod Toxicol 14:147–157CrossRefGoogle Scholar
  56. Wang H, Ichihara G, Ito H, Kato K, Kitoh J, Yamada T et al (2002) Biochemical changes in the central nervous system of rats exposed to 1-bromopropane for 7 days. Toxicol Sci 67:114–120CrossRefGoogle Scholar
  57. Wang H, Ichihara G, Ito H, Kato K, Kitoh J, Yamada T et al (2003a) Dose-dependent biochemical changes in rat central nervous system after 12-week exposure to 1-bromopropane. Neurotoxicology 24:199–206CrossRefGoogle Scholar
  58. Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH et al (2003b) Regulation of cell polarity and protrusion formation by targeting rhoa for degradation. Science 302:1775–1779CrossRefGoogle Scholar
  59. Wang X, Dong C, Sun L, Zhu L, Sun C, Ma R et al (2016) Quantitative proteomic analysis of age-related subventricular zone proteins associated with neurodegenerative disease. Sci Rep 6:37443CrossRefGoogle Scholar
  60. Wible RS, Sutter TR (2017) Soft cysteine signaling network: the functional significance of cysteine in protein function and the soft acids/bases thiol chemistry that facilitates cysteine modification. Chem Res Toxicol 30:729–762CrossRefGoogle Scholar
  61. Wispriyono B, Matsuoka M, Igisu H (2004) Acrylamide does not cause apparent changes in genetic expression of creatine kinase in rat cerebellum. J UOEH 26:51–57CrossRefGoogle Scholar
  62. Zeiger E, Recio L, Fennell TR, Haseman JK, Snyder RW, Friedman M (2009) Investigation of the low-dose response in the in vivo induction of micronuclei and adducts by acrylamide. Toxicol Sci 107:247–257CrossRefGoogle Scholar
  63. Zhang SF, Hennessey T, Yang L, Starkova NN, Beal MF, Starkov AA (2011) Impaired brain creatine kinase activity in huntington’s disease. Neurodegener Dis 8:194–201CrossRefGoogle Scholar
  64. Zong C, Garner CE, Huang C, Zhang X, Zhang L, Chang J et al (2016) Preliminary characterization of a murine model for 1-bromopropane neurotoxicity: role of cytochrome p450. Toxicol Lett 258:249–258CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Daichi Nagashima
    • 1
    • 2
  • Lingyi Zhang
    • 1
  • Yuki Kitamura
    • 3
    • 5
  • Sahoko Ichihara
    • 4
  • Eri Watanabe
    • 1
  • Cai Zong
    • 1
  • Yuko Yamano
    • 2
  • Toshihiro Sakurai
    • 1
  • Shinji Oikawa
    • 3
  • Gaku Ichihara
    • 1
    Email author
  1. 1.Department of Occupational and Environmental Health, Faculty of Pharmaceutical SciencesTokyo University of ScienceNodaJapan
  2. 2.Department of Hygiene and Preventive MedicineShowa UniversityShinagawaJapan
  3. 3.Department of Environmental and Molecular MedicineMie University Graduate School of MedicineMieJapan
  4. 4.Department of Environmental and Preventive MedicineJichi Medical University School of MedicineShimotsukeJapan
  5. 5.College of PharmacyKinjo Gakuin UniversityAichiJapan

Personalised recommendations